Complete Filing Data
Valuence Merger Corp. I reported Stockholders Equity of -$13.07 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Valuence Merger Corp. I did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | $280.3K | $2.4M | $4.8M | $630.6K |
| Operating Income Loss | -$423.5K | $482.5K | -$1.4M | -$2.6M |
| Nonoperating Income Expense | $703.8K | $1.9M | $6.2M | $3.2M |
| General And Administrative Expense | $595.4K | $1.1M | $1.4M | $2.6M |
| Recoveries Of Previously Incurred General And Administrative Expenses | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $156.2K | $58.7K | $25.0K | $35.0K | $168.7K | $588.7K | $629.8K | $1.6M | $1.8M | $110.5K | -$133.3K | -$82.3K | -$9.9K | -$4.9K |
| Operating Income Loss | -$31.6K | -$126.6K | -$156.4K | -$203.1K | -$465.8K | -$257.5K | -$235.6K | -$377.8K | -$654.7K | -$949.0K | -$409.6K | -$96.0K | -$9.9K | -$4.9K |
| Nonoperating Income Expense | $187.8K | $185.3K | $181.3K | $238.2K | $634.5K | $846.2K | $865.4K | $2.0M | $2.4M | $1.1M | $276.3K | $13.7K | ||
| General And Administrative Expense | $82.5K | $126.6K | $277.4K | $203.1K | $465.8K | $257.5K | $235.6K | $377.8K | ||||||
| Recoveries Of Previously Incurred General And Administrative Expenses | $121.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$13.1M | -$12.3M | -$11.9M | -$15.1K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.5K | $61.0K | $684.8K | $319.2K | $178.7K |
| Temporary Equity Carrying Amount Attributable To Parent | $23.2M | $22.2M | $69.3M | $229.9M | |
| Retained Earnings Accumulated Deficit | -$13.1M | -$12.3M | -$11.9M | -$9.5M | -$9.9K |
| Liabilities Current | $5.0M | $4.3M | $4.7M | $2.3M | $620.4K |
| Liabilities And Stockholders Equity | $23.2M | $22.3M | $70.2M | $230.8M | $635.5K |
| Liabilities | $13.1M | $12.4M | $12.8M | $10.4M | $620.4K |
| Assets Current | $13.1K | $109.5K | $762.9K | $841.6K | $178.7K |
| Assets | $23.2M | $22.3M | $70.2M | $230.8M | $635.5K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$59.6K | -$623.8K | $365.6K | $140.5K | |
| Deferred Underwriting Commissions Noncurrent | $8.1M | $8.1M | $8.1M | $8.1M | |
| Assets Held In Trust Noncurrent | $23.2M | $22.2M | $69.4M | $229.9M | |
| Accounts Payable And Accrued Liabilities Current | $757.1K | $766.8K | $2.2M | $2.0M | |
| Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption | -$7.1M | -$26.2M | |||
| Interest Earned On Cash And Investments Held In Trust Account | $703.8K | $1.9M | $6.2M | ||
| Cash And Cash Equivalents At Carrying Value | $319.2K | $178.7K | |||
| Cash | $319.2K | $178.7K | |||
| Accrued Offering Costs Current | $70.0K | $320.0K | |||
| Offering Costs Included In Accrued Offering Costs | $70.0K | ||||
| Repayments Of Related Party Debt | $300.0K | ||||
| Deferred Underwriting Fee Payable | $8.1M | ||||
| Notes Payable Related Parties Classified Current | $300.0K | ||||
| Deferred Costs | $456.8K | ||||
| Common Stock Shares Subject To Forfeiture | 750.0K | ||||
| Other Liabilities Current | |||||
| Repayments Of Other Debt | |||||
| Deferred Offering Costs Paid Through Promissory Note Related Party | |||||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | |||||
| Accretion Of Common Stock Subject To Redemption |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$12.9M | -$12.8M | -$12.5M | -$13.7M | -$13.4M | -$12.6M | -$11.3M | -$11.0M | -$10.2M | -$9.5M | -$8.4M | -$7.4M | -$7.0M | -$4.9K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $43.1K | $92.7K | $69.2K | $15.5K | $20.1K | $25.0K | $624.8K | $118.4K | $169.8K | $463.3K | $544.8K | $965.6K | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $23.0M | $22.7M | $22.4M | $21.9M | $21.6M | $70.5M | $67.9M | $66.9M | $232.4M | $228.1M | $227.0M | $229.9M | ||||
| Retained Earnings Accumulated Deficit | -$12.9M | -$12.8M | -$12.5M | -$13.7M | -$13.4M | -$12.6M | -$11.4M | -$11.0M | -$10.2M | -$8.4M | -$7.4M | -$7.0M | ||||
| Liabilities Current | $4.8M | $4.8M | $4.5M | $5.7M | $5.4M | $4.8M | $4.1M | $3.3M | $2.7M | $1.4M | $618.9K | $731.8K | ||||
| Liabilities And Stockholders Equity | $23.1M | $22.9M | $22.5M | $22.0M | $21.7M | $70.8M | $68.8M | $67.4M | $233.0M | $229.2M | $228.3M | $228.6M | ||||
| Liabilities | $12.9M | $12.9M | $12.6M | $13.8M | $13.5M | $12.9M | $12.2M | $11.4M | $10.8M | $9.5M | $8.7M | $8.8M | ||||
| Assets Current | $68.1K | $137.6K | $69.2K | $103.8K | $131.1K | $158.8K | $834.4K | $459.5K | $642.4K | $1.1M | $1.3M | $1.8M | ||||
| Assets | $23.1M | $22.9M | $22.5M | $22.0M | $21.7M | $70.8M | $68.8M | $67.4M | $233.0M | $229.2M | $228.3M | $228.6M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.2K | -$659.8K | -$149.4K | $786.9K | $178.7K | |||||||||||
| Deferred Underwriting Commissions Noncurrent | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | ||||
| Assets Held In Trust Noncurrent | $23.0M | $22.7M | $22.4M | $21.9M | $21.6M | $70.7M | $67.9M | $66.9M | $232.4M | $228.1M | $227.0M | $226.7M | ||||
| Accounts Payable And Accrued Liabilities Current | $719.0K | $777.9K | $748.9K | $2.5M | $2.5M | $2.3M | $2.4M | $2.5M | $2.4M | $1.1M | $350.5K | $75.00 | ||||
| Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption | -$1.3M | -$1.0M | -$2.4M | -$2.4M | -$1.1M | -$290.0K | -$22.9M | |||||||||
| Interest Earned On Cash And Investments Held In Trust Account | $181.3K | $238.2K | $634.5K | $846.2K | $865.4K | $2.0M | $2.4M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $25.0K | $684.8K | $624.8K | $118.4K | $169.8K | $463.3K | $544.8K | $965.6K | ||||||||
| Cash | $25.0K | $684.8K | $624.8K | $118.4K | $169.8K | $463.3K | $544.8K | $965.6K | ||||||||
| Accrued Offering Costs Current | $70.0K | $70.0K | $70.0K | $533.3K | ||||||||||||
| Offering Costs Included In Accrued Offering Costs | $213.3K | $320.0K | ||||||||||||||
| Repayments Of Related Party Debt | $300.0K | |||||||||||||||
| Deferred Underwriting Fee Payable | $8.1M | |||||||||||||||
| Notes Payable Related Parties Classified Current | ||||||||||||||||
| Deferred Costs | ||||||||||||||||
| Common Stock Shares Subject To Forfeiture | ||||||||||||||||
| Other Liabilities Current | $198.4K | $198.4K | ||||||||||||||
| Repayments Of Other Debt | $10.1K | |||||||||||||||
| Deferred Offering Costs Paid Through Promissory Note Related Party | $5.5K | |||||||||||||||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 20.0K | |||||||||||||||
| Accretion Of Common Stock Subject To Redemption | -$22.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$396.4K | -$949.7K | -$708.5K | -$1.1M |
| Net Cash Provided By Used In Investing Activities | -$308.1K | $49.1M | $166.7M | -$226.7M |
| Net Cash Provided By Used In Financing Activities | $645.0K | -$48.8M | -$165.6M | $228.0M |
| Increase Decrease In Prepaid Expense | -$36.8K | -$29.6K | -$444.4K | $522.4K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$9.8K | -$1.5M | $239.2K | $2.0M |
| Proceeds From Related Party Debt | $645.0K | $810.0K | $198.0K | |
| Payments To Acquire Restricted Investments | $308.1K | $784.1K | $1.1M | $226.7M |
| Payments For Repurchase Of Common Stock | $49.9M | $167.8M | ||
| Payments Of Stock Issuance Costs | $70.0K | $607.8K | ||
| Proceeds From Convertible Debt | $300.0K | $613.2K | ||
| Proceeds From Sale Of Restricted Investments | $49.9M | $167.8M | ||
| Proceeds From Issuance Of Private Placement | $10.4M | |||
| Proceeds From Convertible Promissory Note Related Party | $1.7M | |||
| Payments For Proceeds From Other Deposits | $226.7M | |||
| Proceeds From Sale Of Units Net Of Underwriting Discounts Paid | $218.3M | |||
| Proceeds From Issuance Initial Public Offering | $218.3M | |||
| Increase Decrease In Prepaid Expenses Other | $522.4K | |||
| Increase Decrease In Accrued Liabilities | $2.0M | |||
| Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption | $167.8M | |||
| Share Based Compensation | ||||
| Proceeds From Advances From Related Party | $198.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$125.8K | -$239.8K | -$149.4K | -$966.7K | -$4.9K | |||
| Net Cash Provided By Used In Investing Activities | -$56.0K | -$420.0K | -$226.7M | |||||
| Net Cash Provided By Used In Financing Activities | $190.0K | $228.5M | $178.7K | $4.9K | ||||
| Increase Decrease In Prepaid Expense | -$48.5K | $55.7K | -$49.8K | $870.7K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$17.9K | $73.4K | $455.4K | $75.00 | ||||
| Proceeds From Related Party Debt | $255.0K | $170.0K | $198.0K | $300.0K | $4.9K | |||
| Payments To Acquire Restricted Investments | $56.0K | $420.0K | ||||||
| Payments For Repurchase Of Common Stock | $49.9M | $167.8M | ||||||
| Payments Of Stock Issuance Costs | $144.5K | $111.2K | ||||||
| Proceeds From Convertible Debt | $190.0K | |||||||
| Proceeds From Sale Of Restricted Investments | ||||||||
| Proceeds From Issuance Of Private Placement | $10.4M | |||||||
| Proceeds From Convertible Promissory Note Related Party | ||||||||
| Payments For Proceeds From Other Deposits | $226.7M | |||||||
| Proceeds From Sale Of Units Net Of Underwriting Discounts Paid | $218.3M | |||||||
| Proceeds From Issuance Initial Public Offering | $218.3M | |||||||
| Increase Decrease In Prepaid Expenses Other | $870.7K | |||||||
| Increase Decrease In Accrued Liabilities | $75.00 | |||||||
| Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption | ||||||||
| Share Based Compensation | $5.0K | |||||||
| Proceeds From Advances From Related Party |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Prepaid Expense Current | $11.7K | $48.5K | $78.1K | $522.4K | |
| Accretion Of Ordinary Shares Subject To Possible Redemption | -1.0M | -2.8M | |||
| Operating Costs And Expenses | $2.6M | ||||
| Investment Income Interest | $6.2M | $3.2M | |||
| Working Capital Loans | $913.2K | $913.2K | |||
| Investment Income Net | $703.8K | $1.9M | |||
| Due To Other Related Parties Classified Current | $198.4K | $377.00 | |||
| Adjustments To Additional Paid In Capital Warrant Issued | $10.4M | ||||
| Adjustments To Additional Paid In Capital Fair Value Of Public Warrants Net Of Transaction Costs | $5.9M | ||||
| Recoveries Of Previously Incurred Costs | $171.9K | $1.6M | |||
| Additional Paid In Capital | $24.4K | ||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $325.2K | ||||
| Stock Issued During Period Value New Issues | |||||
| Stock Issued During Period Shares New Issues | |||||
| Other Noncash Expense | |||||
| Fair Value Of Public Warrants Net Of Transaction Costs |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prepaid Expense Current | $25.0K | $45.0K | $88.3K | $111.0K | $133.8K | $209.6K | $341.1K | $472.6K | $641.4K | $769.1K | $870.7K | ||||
| Accretion Of Ordinary Shares Subject To Possible Redemption | -271.8K | -269.4K | -237.4K | -322.2K | -970.5K | -1.3M | -1.0M | -2.4M | -2.4M | ||||||
| Operating Costs And Expenses | $257.5K | $235.6K | $377.8K | $654.7K | $949.0K | $409.6K | $96.0K | $9.9K | $4.9K | ||||||
| Investment Income Interest | $846.2K | $865.4K | $2.0M | $2.4M | $1.1M | $276.3K | $13.7K | ||||||||
| Working Capital Loans | $913.2K | $913.2K | $913.2K | $613.2K | $613.2K | $613.2K | $613.2K | $172.7K | $172.7K | ||||||
| Investment Income Net | $187.8K | $185.3K | $181.3K | $238.2K | $634.5K | $846.2K | |||||||||
| Due To Other Related Parties Classified Current | $198.4K | $198.4K | $198.4K | ||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $10.4M | ||||||||||||||
| Adjustments To Additional Paid In Capital Fair Value Of Public Warrants Net Of Transaction Costs | $5.6M | ||||||||||||||
| Recoveries Of Previously Incurred Costs | $50.9K | ||||||||||||||
| Additional Paid In Capital | |||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | |||||||||||||||
| Stock Issued During Period Value New Issues | $25.0K | ||||||||||||||
| Stock Issued During Period Shares New Issues | 6.7M | ||||||||||||||
| Other Noncash Expense | $4.9K | ||||||||||||||
| Fair Value Of Public Warrants Net Of Transaction Costs | $5.6M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.